Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,936 | N/A | N/A | N/A | N/A |
| Marketable Securities | 23,971 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 680 |
| TOTAL | $30,624 | $N/A | $N/A | $N/A | $680 |
| Non-Current Assets | |||||
| PPE Net | 442 | N/A | N/A | N/A | 2,510 |
| Other Non-Current Assets | 2,232 | 0 | 0 | 0 | 990 |
| TOTAL | $2,674 | $N/A | $N/A | $N/A | $3,500 |
| Total Assets | $33,298 | $N/A | $N/A | $N/A | $4,180 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,658 | 0 | 0 | 0 | 850 |
| Accrued Expenses | 2,540 | N/A | N/A | N/A | 3,170 |
| Other current liabilities | N/A | N/A | N/A | N/A | 6,850 |
| TOTAL | $4,198 | $N/A | $N/A | $N/A | $10,870 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1,310 |
| TOTAL | $184 | $N/A | $N/A | $N/A | $2,590 |
| Total Liabilities | $4,382 | $N/A | $N/A | $N/A | $13,460 |
| Shareholders' Equity | |||||
| Common Shares | 1 | N/A | N/A | N/A | 10 |
| Retained earnings | -54,753 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 77,796 | 0 | 0 | 0 | 130 |
| TOTAL | $28,916 | $N/A | $N/A | $N/A | $77,120 |
| Total Liabilities And Equity | $33,298 | $0 | $0 | $0 | $90,580 |